Sage Therapeutic
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $12,816 | $11,871 | $8,654 | $7,902 |
Gross Profit | 11,327 | 6,593 | 7,247 | 6,633 |
EBITDA | -80,211 | -101,202 | -110,989 | -117,339 |
EBIT | -80,340 | -101,457 | -111,300 | -117,675 |
Net Income | -95,778 | -93,551 | -102,854 | -108,483 |
Net Change In Cash | 12,816 | 11,871 | 8,654 | 7,902 |
Free Cash Flow | -66,560 | -82,365 | -80,437 | -37,832 |
Cash | 81,021 | 99,627 | 101,233 | 173,985 |
Basic Shares | 60,941 | 61,116 | 60,538 | 60,136 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $41,243 | $86,455 | $7,686 | $6,308 |
Gross Profit | 31,799 | 84,296 | 6,873 | 5,755 |
EBITDA | -409,485 | -545,070 | -545,867 | -456,727 |
EBIT | -410,516 | -546,463 | -546,989 | -460,909 |
Net Income | -400,666 | -541,489 | -503,267 | -450,827 |
Net Change In Cash | 41,243 | 86,455 | 7,686 | 6,308 |
Cost of Revenue | -131,533 | -1,367,296 | ||
Free Cash Flow | -267,194 | -541,138 | -460,973 | -378,554 |
Cash | 81,021 | 70,992 | 162,700 | 294,233 |
Basic Shares | 60,765 | 59,836 | 59,306 | 58,670 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.19 |
2024-09-30 | -$1.53 |
2024-06-30 | -$1.70 |
2024-03-31 | -$1.80 |
